In various embodiments, the components of the liposomes can include a) a phospholipid and optionally a lipid that is not a phospholipid; b) a pegylated lipid; c) a peptide-ethylene glycol (EG)-lipid conjugate wherein the peptide is a targeting ligand, and d) one or more drug-conjugated ...
(2018a). Nanoparticle drug delivery systems: an excellent carrier for tumor peptide vaccines. Drug Deliv 25:1319-27.Wang, J.; Hu, X.; Xiang, D. Nanoparticle drug delivery systems: An excellent carrier for tumor peptide vaccines. Drug Deliv. 2018, 25, 1319-1327....
According to the new market research report “Nanoparticle Drug Delivery Systems - Global Market Insights and Sales Trends 2024”, published by QYResearch, the global Nanoparticle Drug Delivery Systems market size is projected to reach USD 9.71 billion by 2029, at a CAGR of 9.7% during the forec...
Nanoparticle-based drug delivery systems improve therapeutic efficacy of cancer treatment. • Recent progresses of drug delivery systems based on chitosan, silica, and PLGA nanoparticles are discussed. • Development of multifunctional and targeting nanoparticles have the potential to further enhance thera...
Nanoparticle drug-delivery systems for peritoneal cancers: a case study of the design, characterization and development of the expansile nanoparticle doi:10.1002/wnan.1451WIREs: Nanomedicine & NanobiotechnologyColby, Aaron H.Oberlies, Nicholas H.Pearce, Cedric J.Herrera, Victoria L.M.Colson,...
Kaul G, Amiji M. Long-circulating poly(ethylene glycol)-modified gelatin nanoparticles for intracellular delivery. Pharm Res. 2002;19:1061–7. CASPubMedGoogle Scholar Kreuter J. Nanoparticulate systems in drug delivery and targeting. J Drug Target. 1995;3:171–3. ...
A. L. Onugwa, C. S. Nwagwu, O. S. Onugwu, A. C. Echezona, C. P. Agbo, S. A. Ihim, P. Emeh, P. O. Nnamani, A. A. Attama, and V. V. Khutoryanskiy, Nanotechnology based drug delivery systems for the treatment of anterior segment eyes diseases, J....
“Our researchers have successfully configured the Dolomite system to fabricate PLGA drug delivery systems for oncology applications, and liposomes for the co-delivery of therapeutics. Advanced liposome formulations co-encapsulating a lipophilic drug in the lipid bilayer and a hydrophilic drug in the ...
nanoparticle-based drug delivery, and small interference , with a focus on how logically engineered nanoparticle delivery systems can be used for personalized... Y Rosen,UM Upadhyay,NM Elman - 《Expert Opinion on Drug Delivery》 被引量: 6发表: 2012年 Intelligent drug delivery systems for the tr...
The encapsulation of targeting agents into nanoscale drug delivery systems (DDS) for cancer therapy has received considerable attention in recent years. The thriving area of cancer nanotechnology provides a unique and comprehensive anticancer approach through early diagnosis, prediction, prevention, and pers...